Form 4: Bioventus Inc. Director Mary Kay Ladone Reports Stock Transaction
SEC Form 4
Director Mary Kay Ladone reports the vesting of 1,814 restricted stock units into Class A Common Stock of Bioventus Inc.
Summary
- On June 16, 2024, Mary Kay Ladone, a director of Bioventus Inc., reported a transaction involving restricted stock units.
- 1,814 restricted stock units vested, converting into 1,814 shares of Class A Common Stock.
- Following the transaction, Ladone directly owns 52,488 shares of Class A Common Stock.
- The transaction was reported on June 18, 2024.
Sentiment
Score: 5
Explanation: This is a routine transaction report, neither particularly positive nor negative.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted equity compensation.
Stakeholder Impact
- The transaction may have a minor dilutive effect on existing shareholders due to the issuance of new shares.
Key Dates
| Date | Description |
|---|---|
| 06/16/2024 | Date of transaction: 1,814 restricted stock units vested. |
| 06/18/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.